RT
DGX icon

Rockland Trust’s Quest Diagnostics DGX Stock Holding History

Rockland Trust’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$205K Sell
967
-254
-21% -$49.9K 0.01% 312
2026
Q1 		$239K Hold
1,221
– – 0.01% 292
2025
Q4 		$212K Buy
+1,221
New +$222K 0.01% 298
2025
Q2 		– Sell
-1,257
Closed -$213K – 276
2025
Q1 		$213K Sell
1,257
-838
-40% -$138K 0.01% 258
2024
Q4 		$316K Sell
2,095
-8
-0.4% -$1.24K 0.02% 228
2024
Q3 		$326K Sell
2,103
-313
-13% -$46.7K 0.02% 228
2024
Q2 		$331K Sell
2,416
-170
-7% -$23.3K 0.02% 241
2024
Q1 		$344K Hold
2,586
– – 0.02% 235
2023
Q4 		$357K Hold
2,586
– – 0.02% 228
2023
Q3 		$315K Sell
2,586
-115
-4% -$15.3K 0.02% 230
2023
Q2 		$380K Hold
2,701
– – 0.02% 220
2023
Q1 		$382K Buy
2,701
+76
+3% +$10.9K 0.02% 217
2022
Q4 		$411K Sell
2,625
-66
-2% -$9.48K 0.03% 215
2022
Q3 		$330K Buy
2,691
+127
+5% +$16.7K 0.02% 213
2022
Q2 		$341K Sell
2,564
-19
-0.7% -$2.59K 0.02% 223
2022
Q1 		$354K Buy
+2,583
New +$360K 0.02% 252

Other funds holding DGX

AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
EB
Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return
CPC
Cookson Peirce & Co Pittsburgh, Pennsylvania $3.04B AUM 94.11% 1-Year Est. Return
WIC
Willis Investment Counsel Gainesville, Georgia $2.1B AUM 24.61% 1-Year Est. Return
AIM
Achmea Investment Management Zeist, Netherlands $4B AUM 31.99% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Rockland Trust's DGX Position: Q2 2026 in Review

Rockland Trust reduced its Quest Diagnostics (DGX) stake by 21% in Q2 2026, selling an estimated $49.9K and leaving 967 shares worth $205K. The position accounts for 0.01% of the portfolio, ranked #312.

Rockland Trust first reported a position in DGX in Q1 2022 and has held it in 16 quarters since. The position peaked at $411K in Q4 2022. 478 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Rockland Trust held 967 shares of Quest Diagnostics worth $205K as of Q2 2026.
  • Rockland Trust sold 254 Quest Diagnostics shares in Q2 2026, an estimated $49.9K.
  • Quest Diagnostics made up 0.01% of Rockland Trust's portfolio in Q2 2026, its #312 holding.
  • Rockland Trust first reported a position in Quest Diagnostics in Q1 2022 and has held it in 16 quarters since.
  • Rockland Trust's Quest Diagnostics position peaked at $411K in Q4 2022.
  • 478 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Rockland Trust's 13F filing for Q2 2026, filed 8 Jul 2026.